<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00136929</url>
  </required_header>
  <id_info>
    <org_study_id>HIC 1999-225</org_study_id>
    <nct_id>NCT00136929</nct_id>
  </id_info>
  <brief_title>Senior PAMI: Primary Angioplasty Versus Thrombolytic Therapy for Acute Myocardial Infarction in the Elderly</brief_title>
  <official_title>A Prospective Randomized Trial of Primary Angioplasty Versus Thrombolytic Therapy for Acute Myocardial Infarction in the Elderly &quot;Senior PAMI&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>PAMI Coordinating Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eli Lilly and Company</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Guidant Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>PAMI Coordinating Center</source>
  <brief_summary>
    <textblock>
      This is a prospective, randomized, multi-center, international trial comparing two
      reperfusion strategies in elderly (age &gt;= 70 years) patients with acute myocardial
      infarction: primary percutaneous coronary intervention (PCI) versus intravenous thrombolytic
      therapy. Clinical endpoints will be collected in the hospital, at 1 month, 6 months, and 1
      year post-randomization. The primary endpoint is 30 day death or disabling stroke. The study
      null hypothesis is that there will be no significant difference in death or disabling stroke
      at 30 days post-randomization between patients treated with PCI versus thrombolytics.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <enrollment>530</enrollment>
  <condition>Myocardial Infarction</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Thrombolytic therapy</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Percutaneous coronary intervention (PCI)</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;= 70

          -  Clinical symptoms &gt; 30 minutes

          -  Symptom onset &lt;= 12 hours

          -  ST segment elevation &gt;= 1 mm in 2 or more leads

        Exclusion Criteria:

          -  Prior thrombolytics

          -  Cardiogenic shock

          -  Cerebrovascular accident (CVA)

          -  Prolonged cardiopulmonary resuscitation (CPR)

          -  Blood pressure (BP) &gt; 180/100 mm Hg

          -  Active bleeding

          -  International Normalized Ratio (INR) &gt; 1.4

          -  Acetylsalicylic acid [aspirin] (ASA) or heparin allergy

          -  History of neutropenia, thrombocytopenia, hepatic dysfunction, or renal insufficiency

          -  Peripheral vascular disease (PVD)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Felix Zijlstra, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ziekenhuis de Weezenlanden</affiliation>
  </overall_official>
  <verification_date>August 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 26, 2005</study_first_submitted>
  <study_first_submitted_qc>August 26, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 29, 2005</study_first_posted>
  <last_update_submitted>December 12, 2005</last_update_submitted>
  <last_update_submitted_qc>December 12, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 13, 2005</last_update_posted>
  <keyword>AMI</keyword>
  <keyword>MI</keyword>
  <keyword>Acute myocardial infarction (AMI), (MI)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrinolytic Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

